TC
LUMO

TFS Capital’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

TFS Capital’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,698
Closed -$585K – 794
2017
Q1 		$585K Sell
2,698
-7,529
-74% -$1.08M 0.19% 168
2016
Q4 		$946K Buy
+10,227
New +$1.15M 0.25% 144
2015
Q3 		– Sell
-2,666
Closed -$1.06M – 1064
2015
Q2 		$1.06M Sell
2,666
-2,553
-49% -$1.08M 0.1% 316
2015
Q1 		$2.57M Buy
+5,219
New +$2.02M 0.25% 90
2013
Q3 		– Sell
-4,242
Closed -$753K – 1656
2013
Q2 		$753K Buy
+4,242
New +$601K 0.03% 734

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

TFS Capital's LUMO Position: Q2 2017 in Review

TFS Capital sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2017, closing a stake of 2,698 shares — an estimated $585K sold.

TFS Capital first reported a position in LUMO in Q2 2013 and held it in 5 quarters. The position peaked at $2.57M in Q1 2015. 110 funds tracked by Wall St. Rank hold LUMO as of Q2 2017.

  • TFS Capital reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • TFS Capital sold 2,698 Lumos Pharma, Inc. Common Stock shares in Q2 2017, an estimated $585K.
  • TFS Capital first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 5 quarters.
  • TFS Capital's Lumos Pharma, Inc. Common Stock position peaked at $2.57M in Q1 2015.
  • 110 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2017.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.